Mutant phosphodiesterase 3A protects the kidney from hypertension-induced damage

Kidney Int. 2023 Aug;104(2):388-393. doi: 10.1016/j.kint.2023.04.026. Epub 2023 May 25.
No abstract available

Keywords: amphiregulin (AREG); cyclic adenosine monophosphate (cAMP); epidermal growth factor receptor (EGFR); phosphodiesterase 3A; renoprotection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cyclic Nucleotide Phosphodiesterases, Type 3
  • Epidermal Growth Factor*
  • ErbB Receptors
  • Humans
  • Hypertension* / complications
  • Kidney

Substances

  • Cyclic Nucleotide Phosphodiesterases, Type 3
  • Epidermal Growth Factor
  • ErbB Receptors

Grants and funding